Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 32
Phase 42

Trial Status

Completed2
Other2

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03535935Phase 2/3Unknown
Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease
Diabetic Kidney DiseaseDiabetic Nephropathies
PrincipalinvestigatorStart date: 2018-07-01
NCT02488252Phase 2/3Unknown
Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy
Diabetic Nephropathies
PrincipalinvestigatorStart date: 2015-07-01
NCT00863252Phase 4Completed
Mycophenolate Mofetil for IgA Nephropathy
IGA Nephropathy
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

The University of Hong Kong

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03535935Phase 2/3PrincipalInvestigator

Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease

Diabetic Kidney DiseaseDiabetic Nephropathies
Unknown
NCT02488252Phase 2/3PrincipalInvestigator

Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy

Diabetic Nephropathies
Unknown
NCT00863252Phase 4PrincipalInvestigator

Mycophenolate Mofetil for IgA Nephropathy

IGA Nephropathy
Completed
NCT01185197Phase 4PrincipalInvestigator

Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study

Nephrosis, Lipoid
Completed

All 4 trials loaded